Cargando…

Lack of clinically relevant differences in safety and pharmacokinetics after second‐dose administration of intranasal diazepam within 4 h for acute treatment of seizure clusters: A population analysis

OBJECTIVE: Current diazepam nasal spray labeling requires waiting 4 h before administering a second dose. The objective of the current analyses was to examine safety and pharmacokinetic profiles of second doses of diazepam nasal spray given 0−4 h after the first dose. METHODS: Two datasets were anal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cascino, Gregory D., Tarquinio, Daniel, Wheless, James W., Hogan, Robert Edward, Sperling, Michael R., Desai, Jay, Vazquez, Blanca, Samara, Emil, Misra, Sunita N., Carrazana, Enrique, Rabinowicz, Adrian L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543781/ https://www.ncbi.nlm.nih.gov/pubmed/35377464 http://dx.doi.org/10.1111/epi.17249

Ejemplares similares

Final results from a Phase 3, long‐term, open‐label, repeat‐dose safety study of diazepam nasal spray for seizure clusters in patients with epilepsy
por: Wheless, James W., et al.
Publicado: (2021)

Overcoming the challenges of developing an intranasal diazepam rescue therapy for the treatment of seizure clusters
por: Cloyd, James, et al.
Publicado: (2021)

Safety of Diazepam Nasal Spray in Pediatric Patients With Developmental Epileptic Encephalopathies: Results From a Long-term Phase 3 Safety Study
por: Tarquinio, Daniel, et al.
Publicado: (2023)

Consistent safety and tolerability of Valtoco(®) (diazepam nasal spray) in relationship to usage frequency in patients with seizure clusters: Interim results from a phase 3, long‐term, open‐label, repeat‐dose safety study
por: Miller, Ian, et al.
Publicado: (2021)

Use of second doses of Valtoco® (diazepam nasal spray) across 24 hours after the initial dose for out‐of‐hospital seizure clusters: Results from a phase 3, open‐label, repeat‐dose safety study
por: Sperling, Michael R., et al.
Publicado: (2022)

Pharmacokinetics and safety of VALTOCO (NRL‐1; diazepam nasal spray) in patients with epilepsy during seizure (ictal/peri‐ictal) and nonseizure (interictal) conditions: A phase 1, open‐label study
por: Hogan, Robert Edward, et al.
Publicado: (2020)

Significant improvements in SEIzure interVAL (time between seizure clusters) across time in patients treated with diazepam nasal spray as intermittent rescue therapy for seizure clusters
por: Misra, Sunita N., et al.
Publicado: (2022)

Evaluation of diazepam nasal spray in patients with epilepsy concomitantly using maintenance benzodiazepines: An interim subgroup analysis from a phase 3, long‐term, open‐label safety study
por: Segal, Eric B., et al.
Publicado: (2021)

Evaluation of Pharmacokinetics and Dose Proportionality of Diazepam After Intranasal Administration of NRL‐1 to Healthy Volunteers
por: Tanimoto, Sarina, et al.
Publicado: (2020)

Use of intranasal rescue therapy for seizure clusters in students with epilepsy: Nurses’ knowledge, perceptions, and practice
por: Santilli, Nancy, et al.
Publicado: (2023)

Bioavailability and safety of diazepam intranasal solution compared to oral and rectal diazepam in healthy volunteers
por: Hogan, R. Edward, et al.
Publicado: (2020)

The nose has it: Opportunities and challenges for intranasal drug administration for neurologic conditions including seizure clusters
por: Chung, Steve, et al.
Publicado: (2022)

A Short Review on the Intranasal Delivery of Diazepam for Treating Acute Repetitive Seizures
por: Boddu, Sai H. S., et al.
Publicado: (2020)

Treatment of Seizure Clusters in Epilepsy: A Narrative Review on Rescue Therapies
por: Becker, Danielle A., et al.
Publicado: (2023)

Lack of Effect of Vortioxetine on the Pharmacokinetics and Pharmacodynamics of Ethanol, Diazepam, and Lithium
por: Chen, Grace, et al.
Publicado: (2016)

Optimizing Absorption for Intranasal Delivery of Drugs Targeting the Central Nervous System Using Alkylsaccharide Permeation Enhancers
por: Madden, Stuart, et al.
Publicado: (2023)

A Physiologically Based Pharmacokinetic Model for Predicting Diazepam Pharmacokinetics after Intravenous, Oral, Intranasal, and Rectal Applications
por: Khalid, Sundus, et al.
Publicado: (2021)

Improvement of Intranasal Drug Delivery with Intravail(®) Alkylsaccharide Excipient as a Mucosal Absorption Enhancer Aiding in the Treatment of Conditions of the Central Nervous System
por: Rabinowicz, Adrian L., et al.
Publicado: (2021)

Intranasal Midazolam Compared with Intravenous Diazepam in Patients Suffering from Acute Seizure: A Randomized Clinical Trial
por: Javadzadeh, Mohsen, et al.
Publicado: (2012)

Future opportunities for research in rescue treatments
por: Wheless, James W., et al.
Publicado: (2022)

Response to diazepam in children with malaria induced seizures
por: Ikumi, M.L., et al.
Publicado: (2008)

Implications of Seizure-Cluster Treatment on Healthcare Utilization: Use of Approved Rescue Medications
por: Rabinowicz, Adrian L, et al.
Publicado: (2022)

Acute seizure therapies in people with epilepsy: Fact or fiction? A U.S. Perspective
por: Tatum, William O., et al.
Publicado: (2023)

Effect of diazepam on sociability of rats submitted to neonatal seizures
por: Leite, Ingrid Stanize, et al.
Publicado: (2016)

Diazepam/sodium-valproate: Lack of efficacy: case report
Publicado: (2021)

Oral Diazepam in Febrile Seizures Following Acellular Pertussis Vaccination
por: Ghazavi, Mohammadreza, et al.
Publicado: (2019)

Diazepam/olanzapine: Lack of efficacy and drowsiness: 2 case reports
Publicado: (2022)

Inhibitory Effect of Imperatorin on the Pharmacokinetics of Diazepam In Vitro and In Vivo
por: Zhou, Yunfang, et al.
Publicado: (2020)

Pharmacokinetics of Diazepam and Its Metabolites in Urine of Chinese Participants
por: Wang, Le-le, et al.
Publicado: (2022)

Clay Nanotubes Loaded with Diazepam or Xylazine Permeate the Brain through Intranasal Administration in Mice
por: Yanamadala, Yaswanthi, et al.
Publicado: (2023)

Comparison of Intranasal and Intravenous Diazepam on Status Epilepticus in Stroke Patients: A Retrospective Cohort Study
por: Inokuchi, Ryota, et al.
Publicado: (2015)

Diazepam Monotherapy or Diazepam-Ketamine Dual Therapy at Different Time Points Terminates Seizures and Reduces Mortality in a Status Epilepticus Animal Model
por: Zhou, Ruijiao, et al.
Publicado: (2021)

A Comparison of Buccal Midazolam and Intravenous Diazepam for the Acute Treatment of Seizures in Children
por: Tonekaboni, Seyed-Hassan, et al.
Publicado: (2012)

A Combination of Curcuma longa and Diazepam Attenuates Seizures and Subsequent Hippocampal Neurodegeneration
por: Nascimento, Chirlene Pinheiro, et al.
Publicado: (2022)

Diazepam/mrna-1273: Status epilepticus, fever and lack of efficacy: case report
Publicado: (2021)

Constant rate infusion of diazepam or propofol for the management of canine cluster seizures or status epilepticus
por: Cagnotti, Giulia, et al.
Publicado: (2022)

Duration of constant rate infusion with diazepam or propofol for canine cluster seizures and status epilepticus
por: Cagnotti, Giulia, et al.
Publicado: (2023)

Clarification of Dalfampridine Labeled Indications
por: Rabinowicz, Adrian L., et al.
Publicado: (2012)

Comparison of Intravenous Midazolam Drip with Intermittent Intravenous Diazepam in the Treatment of Refractory Serial Seizures in Children
por: FAYYAZI, Afshin, et al.
Publicado: (2012)

VALTOCO(®) (Diazepam Nasal Spray) for the Acute Treatment of Intermittent Stereotypic Episodes of Frequent Seizure Activity
por: Cornett, Elyse M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lsoe1k787sj3ulm0br35o80sde